At Golden Helix, we’re committed to advancing precision oncology through robust software solutions that streamline clinical workflows. As the field of cancer genomics continues to evolve, staying informed about the latest best practices and tools is more important than ever. That’s why we’re excited to announce the release the second edition of Clinical Variant Analysis for Cancer eBook from our CEO, Dr. Andreas Scherer.
This morning I released a new version of my eBook “Clinical Variant Analysis for Cancer – Second Edition.”
The clinical utilization of Next-Generation Sequencing data to diagnose cancer has taken off, resulting in the need to standardize the interpretation and reporting of observed genomic variations. This eBook explores the entire clinical diagnostic process. It demonstrates how Golden Helix software can support clinicians with their decision making in concordance with the guidelines issued by the College of American Pathologists (AMP). In this revision, I have also included a few examples of our new Drugs & Trials functionality as well as some information about the new annotation sources we have been curating.
To receive a complimentary copy, please visit the following link: https://www.goldenhelix.com/resources/ebooks/cancer-clinical-variant-analysis.html.
Whether you’re a clinical researcher, pathologist, or laboratory director, this updated eBook offers valuable insights into streamlining cancer variant interpretation using a standardized and guideline-driven approach. Dr. Scherer’s expertise and the powerful tools developed by Golden Helix come together to address real-world challenges faced in oncology diagnostics. We encourage you to download your free copy and discover how our software can support your mission to deliver accurate, timely, and actionable results in the fight against cancer.
